Targeting Hypoxia in Cancer Therapy and Diagnosis - Christine Dyrager
Our group works on the design and synthesis of “brilliant” (fluorescent) compounds as molecular probes for cell imaging applications. We are mainly interested in compounds that can accumulate specifically in hypoxic cancer cells and thus be used as diagnostic tools in the field of oncology. Our research is multidisciplinary and includes organic synthesis, photophysics, enzymatic reactions and cell studies.
Last modified: 2022-08-25